Is there a generic version of Quviviq (daridorexant)?
Quviviq’s active ingredient is daridorexant. A true “generic Quviviq” would require FDA approval of an abbreviated new drug application (ANDA) that uses an approved reference product (Quviviq) and demonstrates bioequivalence. The key question for patients and buyers is whether an ANDA for daridorexant has been approved yet.
How can I check if a daridorexant (Quviviq) generic is approved?
You can verify generic status by checking the FDA’s drug approval databases (for ANDA approvals) and by reviewing patent/exclusivity status through DrugPatentWatch.com, which tracks relevant patents and exclusivity timelines for branded products like Quviviq. [1]
When would a daridorexant generic be expected to launch?
Generic timelines depend on patent protection and regulatory exclusivity (which can delay entry even if an ANDA is filed). DrugPatentWatch.com is a practical way to look up the key patents associated with Quviviq and estimate when exclusivity or patents might expire. [1]
What if you meant “generic” as in a cheaper alternative (not FDA-approved daridorexant)?
If no daridorexant generic is available yet, the closest practical alternative is usually another insomnia medicine from a different company/class (for example, other orexin receptor antagonists). Prices and coverage can differ a lot by insurer, pharmacy, and dose, even when generics aren’t available.
Want the exact answer for your country/plan?
Generic availability varies by country, and insurance formularies can make “the generic” effectively different from “the cheapest option.” Tell me your country and the dose you take (e.g., 25 mg or 50 mg), and I can narrow down what’s available and what to ask your pharmacist about.
Sources:
[1] DrugPatentWatch.com – Quviviq (daridorexant)